Reta 20mg
Retatrutide is a synthetic triple agonist peptide that targets GLP-1, GIP, and glucagon receptors. It represents a new class of multi-pathway peptide tools used in metabolic and endocrine research. Retatrutide is currently studied in preclinical environments for its potential role in appetite regulation, glucose metabolism, and energy expenditure.
This 20mg vial provides a high-purity, lyophilized format for advanced in-vitro and ex-vivo studies in metabolic function, receptor signaling, and peptide pharmacodynamics.
Compound: Retatrutide
Strength: 20 mg (Lyophilized powder)
Purity: ≥99%
Form: Research-grade peptide
Storage: Store at -20°C. Protect from light and moisture.
Reconstitution: Suitable for reconstitution in sterile bacteriostatic water (consult protocols).
Intended use For laboratory research only. Not for human consumption.
This product is provided for preclinical studies, biochemical pathway analysis, or academic research investigating receptor activity, metabolic function, or peptide pharmacodynamics.
Retatrutide is a synthetic triple agonist peptide that targets GLP-1, GIP, and glucagon receptors. It represents a new class of multi-pathway peptide tools used in metabolic and endocrine research. Retatrutide is currently studied in preclinical environments for its potential role in appetite regulation, glucose metabolism, and energy expenditure.
This 20mg vial provides a high-purity, lyophilized format for advanced in-vitro and ex-vivo studies in metabolic function, receptor signaling, and peptide pharmacodynamics.
Compound: Retatrutide
Strength: 20 mg (Lyophilized powder)
Purity: ≥99%
Form: Research-grade peptide
Storage: Store at -20°C. Protect from light and moisture.
Reconstitution: Suitable for reconstitution in sterile bacteriostatic water (consult protocols).
Intended use For laboratory research only. Not for human consumption.
This product is provided for preclinical studies, biochemical pathway analysis, or academic research investigating receptor activity, metabolic function, or peptide pharmacodynamics.
Retatrutide is a synthetic triple agonist peptide that targets GLP-1, GIP, and glucagon receptors. It represents a new class of multi-pathway peptide tools used in metabolic and endocrine research. Retatrutide is currently studied in preclinical environments for its potential role in appetite regulation, glucose metabolism, and energy expenditure.
This 20mg vial provides a high-purity, lyophilized format for advanced in-vitro and ex-vivo studies in metabolic function, receptor signaling, and peptide pharmacodynamics.
Compound: Retatrutide
Strength: 20 mg (Lyophilized powder)
Purity: ≥99%
Form: Research-grade peptide
Storage: Store at -20°C. Protect from light and moisture.
Reconstitution: Suitable for reconstitution in sterile bacteriostatic water (consult protocols).
Intended use For laboratory research only. Not for human consumption.
This product is provided for preclinical studies, biochemical pathway analysis, or academic research investigating receptor activity, metabolic function, or peptide pharmacodynamics.
Retatrutide – 20 mg | Research Peptide
Molecular Formula: C305H468N84O94
Molecular Weight: ~6980 Da
CAS Number: Not officially assigned (as of 2025)
Sequence Type: Synthetic peptide analog (GLP-1/GIP/Glucagon receptor agonist)
Peptide Class: Multi-agonist incretin mimetic
Form: Lyophilized white/off-white powder
Purity: ≥99% (HPLC Verified)
Storage Conditions:
Unreconstituted: -20°C
After reconstitution: Store at 2–8°C for short-term use
Solubility: Soluble in sterile water or bacteriostatic saline
Intended Use: For in-vitro laboratory research only. Not for human or animal use.
Chemical Structure & Mechanism
Structure Overview:
Retatrutide is a synthetic linear peptide, engineered as a triagonist of three key metabolic receptors:
GLP-1R (Glucagon-Like Peptide-1 Receptor)
GIPR (Gastric Inhibitory Polypeptide Receptor)
GCGR (Glucagon Receptor)
The backbone of Retatrutide is a modified peptide sequence derived from natural incretins, with specific amino acid substitutions and C-terminal amidation to improve receptor binding affinity and half-life. The compound also includes fatty acid conjugation (often C18-type) at strategic lysine residues to enhance plasma stability and albumin binding.
Mechanism of Action:
Retatrutide functions by activating all three receptors, leading to:
Enhanced insulin secretion (via GLP-1 and GIP receptors)
Appetite suppression and delayed gastric emptying
Increased energy expenditure (via glucagon receptor activation)
Improved glucose and lipid metabolism in preclinical models
Scientific Applications
Retatrutide 20mg is widely used in:
Metabolic pathway analysis
Obesity and diabetes research
Appetite and satiety hormone signaling
Studies of peptide-based therapeutics
Glucose homeostasis experiments in cell or rodent models